The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit, multidisciplinary, professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies via research, education and advocacy.
The purposes of the Society are:
Promoting the association of persons interested in the fields of heart and lung transplantation, end-stage heart and lung disease and related sciences;
Encouraging and stimulating basic and clinical research in heart and lung transplantation and end-stage heart and lung disease, and promoting new therapeutic strategies;
Holding scientific meetings featuring presentations and discussions relevant to heart and lung transplantation and the treatment of end-stage heart and lung disease;
- Sponsoring a scientific journal for the publication of manuscripts related to these disciplines;
- Maintaining an international registry for heart and lung transplantation;
Awarding research grants and establishing endowments for the study of heart and lung transplantation and end-stage heart and lung disease, when funds are available and without jeopardizing the financial well-being of the organization; and
Sponsoring and conducting educational activities and providing educational resources, which promote expert development and improve standards of care in advanced heart and lung disease, heart and lung transplantation, and relevant medical and device therapies.